Cary Street Partners’s Alerian MLP ETF AMLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.5M Buy
299,656
+5,337
+2% +$280K 0.34% 68
2026
Q1
$15.5M Buy
294,319
+37,081
+14% +$1.89M 0.38% 60
2025
Q4
$12.1M Buy
257,238
+41,186
+19% +$1.93M 0.3% 81
2025
Q3
$10.1M Sell
216,052
-307
-0.1% -$14.8K 0.26% 90
2025
Q2
$10.6M Buy
216,359
+96,545
+81% +$4.68M 0.3% 85
2025
Q1
$6.22M Buy
119,814
+2,068
+2% +$106K 0.2% 121
2024
Q4
$5.67M Buy
+117,746
New +$5.66M 0.18% 123

Other funds holding AMLP

Cary Street Partners's AMLP Position: Q2 2026 in Review

Cary Street Partners increased its Alerian MLP ETF (AMLP) stake by 1.8% in Q2 2026, buying an estimated $280K and bringing the position to 299,656 shares worth $15.5M. The position accounts for 0.34% of the portfolio, ranked #68.

Cary Street Partners first reported a position in AMLP in Q4 2024 and has held it in 7 quarters since. 807 funds tracked by Wall St. Rank hold AMLP as of Q2 2026.

  • Cary Street Partners held 299,656 shares of Alerian MLP ETF worth $15.5M as of Q2 2026.
  • Cary Street Partners bought 5,337 Alerian MLP ETF shares in Q2 2026, an estimated $280K.
  • Alerian MLP ETF made up 0.34% of Cary Street Partners's portfolio in Q2 2026, its #68 holding.
  • Cary Street Partners first reported a position in Alerian MLP ETF in Q4 2024 and has held it in 7 quarters since.
  • 807 funds tracked by Wall St. Rank held Alerian MLP ETF as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.